Metabolic Comorbidities in Pediatric Atopic Dermatitis: A Narrative Review

Edoardo De Simoni1, Giulio Rizzetto1, Elisa Molinelli1

  • 1Clinic of Dermatology, Department of Clinical and Molecular Sciences, Polytechnic University of Marche, 60126 Ancona, Italy.

Life (Basel, Switzerland)
|January 21, 2023
PubMed

Insights

Atopic dermatitis (AD) in children is linked to higher rates of metabolic issues like obesity and high blood pressure. Early evaluation and treatment of these comorbidities are crucial to prevent long-term cardiovascular risks.

Area of Science:

  • Dermatology
  • Pediatrics
  • Metabolic Health

Background:

  • Atopic dermatitis (AD) affects 10-20% of children, presenting as chronic, itchy skin inflammation.
  • Children with AD exhibit a higher prevalence of metabolic comorbidities, including metabolic syndrome, obesity, and hypertension, compared to healthy peers.
  • The link between AD and metabolic issues involves immune system deregulation and chronic inflammation.

Purpose of the Study:

  • To highlight the underestimation of metabolic comorbidities in pediatric atopic dermatitis.
  • To emphasize the association between AD, metabolic disorders, and long-term cardiovascular risks in children.
  • To advocate for early evaluation and management of metabolic issues in children with AD.

Main Methods:

  • Review of existing literature on atopic dermatitis and metabolic comorbidities in pediatric populations.
  • Analysis of the immunological pathways linking AD, adipose tissue dysfunction, and inflammation.
  • Examination of epidemiological data on the prevalence of metabolic syndrome, obesity, dyslipidemia, and hypertension in children with AD.

Main Results:

  • Patients with AD, particularly children, show a significantly higher incidence of metabolic syndrome, overweight, obesity, dyslipidemia, and arterial hypertension.
  • Hypertrophic adipose tissue in AD contributes to inflammation via adipokines, promoting a pro-inflammatory state and hypersensitivity.
  • These metabolic disorders in pediatric AD are often overlooked but are associated with significant long-term sequelae and increased cardiovascular risk.

Conclusions:

  • Metabolic comorbidities are frequently associated with atopic dermatitis in children and are often underestimated.
  • Early identification and management of metabolic disorders in pediatric AD are essential for mitigating long-term health consequences, including cardiovascular events.
  • Addressing metabolic health in conjunction with skin care is vital for improving the overall prognosis and reducing future cardiovascular morbidity in affected children.

Related Concept Videos

Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
502
Skin Diseases and Disorders01:23

Skin Diseases and Disorders

Skin is the first line of defense and encounters a variety of microbes. Some pathogenic strains are often the cause of a broad range of infections of the skin and other body systems. These conditions can affect people of all ages and may have different causes, including genetic factors, infections, autoimmune reactions, environmental factors, and lifestyle choices.
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
4.0K
Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.8K
Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.6K
COPD: Pathogenesis and Clinical Features01:20

COPD: Pathogenesis and Clinical Features

Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
421
Asthma-III: Symptoms and Complications01:24

Asthma-III: Symptoms and Complications

Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
2.6K